Antiviral Efficacy of Molnupiravir for COVID-19 Treatment

The ongoing global pandemic of COVID-19 poses unprecedented public health risks for governments and societies around the world, which have been exacerbated by the emergence of SARS-CoV-2 variants. Pharmaceutical interventions with high antiviral efficacy are expected to delay and contain the COVID-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Yuan, Shen, Mingwang, Zhang, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031952/
https://www.ncbi.nlm.nih.gov/pubmed/35458493
http://dx.doi.org/10.3390/v14040763

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031952/
https://www.ncbi.nlm.nih.gov/pubmed/35458493
http://dx.doi.org/10.3390/v14040763

Ejemplares similares